GET DAILY SIGNALSExponent (EXPO) Reports Strong Third-Quarter Results and Raises Full-Year Outlook
Key Takeaways
- Total revenues climbed 18% year over year to $173.7 million, while net revenues (revenues before reimbursements) rose 12% to $153.1 million.
- Diluted earnings per share (EPS) increased 16% to $0.64, topping consensus estimates of roughly $0.60 to $0.63.
- Net income grew 10% to $30.9 million, and EBITDA (earnings before interest, taxes, depreciation, and amortization) rose 16% to $45.0 million.
- Consultant utilization improved to 76.7% from 74.1% a year earlier, and the realized billing rate increased about 4%.
- Management raised full-year guidance, now expecting net revenues to grow 10% to 11% with an EBITDA margin of 28.0% to 28.3%.
- The company declared a regular quarterly dividend of $0.31 per share, payable on December 18, 2026.
Earnings in Context
Exponent, Inc. (EXPO) operates as a science and engineering consulting firm focused on product failure analysis, litigation support, and user research. Its performance offers a window into corporate spending on specialized technical expertise amid uncertain economic conditions. After a strong second quarter, the third-quarter report showed whether that momentum could continue. The results delivered double-digit gains in revenues, earnings, and margins, underscoring resilient demand for the firm’s services. With artificial intelligence representing a larger portion of operations and management raising its outlook, the quarter provides clearer signals on both near-term execution and the sustainability of longer-term growth drivers. I also checked comparable names in the space using Tickeron’s AI Screener to put these trends in perspective.
Reported Results
For the third quarter of fiscal 2026 ended October 2, 2026, total revenues reached $173.7 million, up 18% from $147.1 million a year earlier. Net revenues, the measure management emphasizes, advanced 12% to $153.1 million from $137.1 million. The difference stems from higher reimbursable expenses that pass through total revenues without contributing to profitability.
Net income rose 10% to $30.9 million, and diluted EPS climbed 16% to $0.64 from $0.55. The figure exceeded consensus forecasts in the $0.60 to $0.63 range. EBITDA increased 16% to $45.0 million, yielding a margin of 29.4% of net revenues compared with 28.3% in the prior-year quarter.
Operating metrics remained solid. Billable hours grew 8% to roughly 405,000, utilization moved up to 76.7%, and average technical full-time equivalent headcount rose 4% to 1,016. The engineering and other scientific segment, accounting for 85% of net revenues, expanded 13%, while the environmental and health segment, representing 15%, grew 3%.
Market Reaction and Investor Sentiment
Coming into the quarter, expectations were already elevated after the second-quarter beat. The latest results again surpassed consensus on both revenue and earnings lines. EXPO has now topped EPS estimates for four straight quarters, which has helped sustain investor confidence. Management’s decision to raise full-year guidance added further support, suggesting the gains reflect more than just favorable project timing.
Commentary on artificial intelligence also drew attention. Management indicated AI is a direct component of roughly 15% to 20% of the business this year. Combined with higher utilization and an improved billing rate, the update framed the quarter as evidence of both demand strength and disciplined operations. I reviewed the AI-related commentary against broader sector data via Tickeron’s AI Trend Prediction Engine to confirm the positioning.
Forward Outlook and Key Factors to Monitor
Guidance was lifted for the balance of the fiscal year. For the fourth quarter, net revenues before reimbursements are expected to grow 8% to 10% year over year, with EBITDA projected at 26.3% to 26.8% of net revenues. For full fiscal 2026, management now forecasts net revenue growth of 10% to 11% and an EBITDA margin of 28.0% to 28.3%.
Several items warrant close attention going forward. Utilization and headcount trends will show whether the firm can scale while managing compensation pressures amid competition for engineering talent. The pace of user research and AI-related work will indicate whether the fastest-growing demand areas remain intact.
Capital allocation is another focus. Through the first three quarters, EXPO repurchased $146.1 million of stock and continues paying a quarterly dividend while holding $114.7 million in cash. How management balances returns to shareholders with investments in infrastructure and talent will influence profitability and growth. These factors, more than any single quarter’s numbers, are likely to shape the stock’s path ahead.
Enhancing Research with Tickeron Tools
When preparing this review, I turned to Tickeron’s AI Screener to compare EXPO with industry peers and surface similar opportunities. The tool provides a practical way to apply customizable filters across fundamentals, patterns, and performance metrics, helping refine the analysis efficiently.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
EXPO in upward trend: 10-day moving average broke above 50-day moving average on October 12, 2026
The 10-day moving average for EXPO crossed bullishly above the 50-day moving average on October 12, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 79%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 05, 2026. You may want to consider a long position or call options on EXPO as a result. In 48 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 55%.
The Moving Average Convergence Divergence (MACD) for EXPO just turned positive on October 02, 2026. Looking at past instances where EXPO's MACD turned positive, the stock continued to rise in 27 of 45 cases over the following month. The odds of a continued upward trend are 60%.
EXPO moved above its 50-day moving average on October 05, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +0.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where EXPO advanced for three days, in 162 of 278 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.
The Aroon Indicator entered an Uptrend today. In 126 of 222 cases where EXPO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 17 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
EXPO broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 31 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 39 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. EXPO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.901) is normal, around the industry mean (15.756). P/E Ratio (34.960) is within average values for comparable stocks, (169.208). Projected Growth (PEG Ratio) (2.730) is also within normal values, averaging (3.522). Dividend Yield (0.016) settles around the average of (0.183) among similar stocks. P/S Ratio (5.402) is also within normal values, averaging (2.960).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EXPO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a engineering and scientific consulting company
Industry EngineeringConstruction
Advertisement